Skip to content

Research on the Functional Effects of Traditional Chinese Medicine on the Human Body with Ultra-High Sensitivity and Extremely Magnetic Fields

Multi-Dimensional Quantitative Evaluation Technology and Equipment for the Functional Effects of Traditional Chinese Medicine Based on Extremely Magnetic Field Measurement

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025000643
Enrollment
Unknown
Registered
2025-04-02
Start date
2024-04-26
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Observation group (insomnia coexisting with cardiovascular disease group):None.Only conducted instrument testing without any intervention
Observation group (insomnia group):None.Only conducted instrument testing without any intervention
control group:None,we only conducted instrument testing without any intervention

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Control Group (Healthy Group): (1)Age 18-75 years gender not restricted. (2)No significant organic diseases. (3)Insomnia Severity Index (ISI) score 7. (4)Voluntary signing of the informed consent form. All of the above conditions must be met for inclusion. Insomnia Disorder Comorbid with Cardiovascular and Cerebrovascular Diseases Group: (1)Age 18-75 years gender not restricted. (2)Meets the diagnostic criteria for insomnia disorder in Western medicine. (3)Insomnia Severity Index (ISI) score > 7. (4)Meets the diagnostic criteria for any one of the following diseases: coronary atherosclerotic heart disease arrhythmia heart failure myocardial infarction ischemic stroke or cerebral hemorrhage and the condition is stable as judged by a specialist physician. (5)Voluntary signing of the informed consent form. All of the above conditions must be met for inclusion.

Exclusion criteria

Exclusion criteria: Exclusion Criteria for the Control Group (Healthy Group): (1)Meets the diagnostic criteria for any disease in DSM-IV. (2)Presence of severe cardiovascular cerebrovascular pulmonary hepatic renal or endocrine diseases. (3)Pregnant or breastfeeding women. (4)Use of medications that may affect the study results within the past 2 weeks (e.g. hormones). (5)Other situations deemed inappropriate for inclusion in the study. Exclusion Criteria for the Insomnia Disorder Group: (1)Insomnia caused by other types of sleep disorders (e.g. sleep apnea syndrome restless legs syndrome). (2)Individuals planning to become pregnant pregnant breastfeeding or those who need to sleep with children. (3)Patients diagnosed with severe depression based on the Patient Health Questionnaire-9 (PHQ-9) (total score =15). (4)Patients diagnosed with severe anxiety based on the Generalized Anxiety Disorder 7-item scale (GAD-7) (total score =15). (5)Presence of severe cardiovascular cerebrovascular pulmonary hepatic renal or endocrine diseases. (6)Individuals with mental retardation alcohol or other substance abuse or dependence or other psychiatric disorders. (7)Pregnant or breastfeeding women. (8)Patients with metal implants or pacemakers. (9)Inability to complete the relevant assessments or tests. Exclusion Criteria for the Insomnia Disorder Comorbid with Cardiovascular and Cerebrovascular Diseases Group: (1)Insomnia caused by other types of sleep disorders (e.g. sleep apnea syndrome restless legs syndrome). (2)Individuals planning to become pregnant pregnant breastfeeding or those who need to sleep with children. (3)Patients diagnosed with severe depression based on the Patient Health Questionnaire-9 (PHQ-9) (total score =15). (4)Patients diagnosed with severe anxiety based on the Generalized Anxiety Disorder 7-item scale (GAD-7) (total score =15). (5)Presence of severe diseases in the cardiovascular hepatic renal or endocrine systems (e.g. severe arrhythmia acute myocardial infarction severe heart failure hypertensive emergency liver failure renal failure acute complications of diabetes). (6)Individuals with mental retardation alcohol or other substance abuse or dependence or other psychiatric disorders. (7)Pregnant or breastfeeding women. (8)Patients with metal implants or pacemakers. (9)Inability to complete the relevant assessments or tests.

Design outcomes

Primary

MeasureTime frame
Cardiac magnetic signal;

Secondary

MeasureTime frame
Heart rate variability;Pulse to respiratory ratio;

Countries

China

Contacts

Public ContactYang Zhimin

Guangdong Provincial Hospital of Chinese Medicine

yangyo@163.net020-81887233-32406

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026